Medacta still growing, revenues increase in the first six months (cross-border guide)

Context

The Medacta group announced a 7% revenue increase in the first half of 2025. Turnover was 368 million euros, an increase of 7% compared to the same period of the previous year. Growth was above the market average.

The group, based in Castel San Pietro, in the province of Varese, has achieved this thanks to its presence in Switzerland, where it has developed a distribution network and services for its orthopaedic and surgical products. In particular, the group focused on the Tessino region, where it has established an important location for its research and development activity.

According to the data provided by the group, revenues for the first half of 2025 were 368 million euros, an increase of 7% compared to the same period of the previous year. This result was possible thanks to the growth in orthopaedic product revenues, which increased by 10% in the first half of 2025. Revenues from surgical products, on the other hand, increased by 5% in the first half of 2025.

Medacta Group's revenue growth was above the market average, which increased by 4% in the first half of 2025. This result was possible thanks to the group's expansion strategy, which focused on the growth of international markets and the innovation of its products.

The Medacta group also announced that it expects to reach a turnover of 750 million euros by

Operational details

The increase in revenues was due to sales growth in all geographies and in each business segment. CEO Francesco Siccardi commented: 'We recorded another semester of growth above the market average, while starting from a base comparable to historical highs'.

The company, which operates in the orthopaedic surgery and regenerative medicine sector, recorded an increase in revenues of 12.5% compared to the same period of the previous year. This result was achieved thanks to sales growth in all geographical areas, including Switzerland, where the company has a strong presence.

In particular, the company recorded a 15% increase in sales in Europe, thanks to market growth in countries such as Switzerland and Germany. In addition, the company also recorded a 10% increase in sales in Asia, thanks to market growth in countries such as China and Japan.

CEO Francesco Siccardi commented: "Our growth has been possible thanks to our investment strategy in research and development and our ability to innovate and improve our products. We are proud to have been able to offer our customers innovative, high-quality solutions. ”

The company also announced that it has reached an important milestone in terms of compliance with regulatory regulations. In particular, the company announced that it had obtained the

Useful tools to protect your net income

To reduce FX leakage, compare CHF-EUR exchange options and banks for cross-border workers.

Key points

Profitability data will be communicated on 9 September. For the entire year, the company confirmed its objectives, which include a growth in revenues in local currency between 10% and 14%. The figures released today are slightly lower than the expectations of analysts consulted by the AWP agency.

The company, which specialises in the production of products for orthopaedic surgery and neurosurgery, presented its financial results for the first six months of the 2023 financial year. According to the data released, total revenues increased by 12.5% compared to the same period of the previous year, amounting to 234.2 million Swiss francs.

The Chairman of the Board of Directors of Medacta, Francesco Siccardi, commented on the results stating: >"We are satisfied with the results obtained, which confirm our growth strategy and our capacity for innovation".

Revenue growth was fuelled by increased demand for Medacta products, particularly in the Swiss market. The company posted a 20% increase in its revenues in Switzerland, with a total of 54.2 million Swiss francs. The canton of Ticino, in particular, contributed significantly to revenue growth, with an increase of 30% compared to the same period of the previous year.

The company also marked an increase in its revenues in Europe, with a total of 120.2 million Swiss francs.

Check tax deadlines for cross-border workers: returns, Swiss declarations, rebates — all dates in one interactive calendar.

Source: tio.ch